Key result
PCI in CTO shows improved heart function and similar major cardiovascular events regardless of diabetes status.
Why the study?
The effects of PCI on coronary chronic total occlusion patients with and without diabetes mellitus were compared to understand differential impacts on viable myocardium and heart function.
Does percutaneous coronary intervention improve viable myocardium and heart function similarly in chronic total occlusion patients with and without diabetes mellitus?
Cohort (n=78)
Does percutaneous coronary intervention improve viable myocardium and heart function similarly in chronic total occlusion patients with and without diabetes mellitus?
PCI for chronic total occlusion improves viable myocardium and left ventricular function at 6 months regardless of the presence of diabetes mellitus.
Answers are grounded in this paper and cite their sources.
PCI may confer similar benefits on viable myocardium and LVEF in CTO patients with or without DM; leaves open confirmation in prospective trials.
OBJECTIVE: The aim of this study was to compare the effects of percutaneous coronary intervention (PCI) on coronary chronic total occlusion patients with (DM) or without (NDM) diabetes mellitus. METHODS: A total of 78 patients were divided into DM group and NDM group according to whether the patient has DM. The results of PCI were analyzed using quantitative coronary analysis. In addition, all the patients underwent Tc-MIBI (methoxyisobutylisonitrile) single-photon emission computed tomography (SPECT) and ultrasonic cardiogram in the first week and the sixth month after PCI to evaluate PCI results. During the 6-month follow-up, major adverse cardiac event (MACE) was recorded and analyzed as well. RESULTS: The first and second classes of collateral circulation between the 2 groups have significant differences (P < 0.05). Left ventricular end-diastolic volume index and left ventricular end-systolic volume index were decreased at the sixth month compared with those at the first week. Left ventricular ejection fraction was significantly increased. In both groups, the defect size significantly reduced, and percentage of radionuclide scintigraphic count significantly increased between rest and nitroglycerin interventional SPECT. After 6 months, both groups repeated nitroglycerin interventional SPECT, which showed that defect size was significantly reduced, and the percentage of radionuclide scintigraphic count was significantly increased compared with those of the first week. During the 6-month follow-up, the incidence of MACE between the 2 groups had no significant difference. CONCLUSIONS: Percutaneous coronary intervention has beneficial effects on heart functions and MACE when performed on chronic total occlusion patients with and without DM.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2017) conducted a cohort in chronic total occlusion (n=78). Diabetes Mellitus vs. No Diabetes Mellitus was evaluated on Major adverse cardiac event (MACE) and heart function. Percutaneous coronary intervention improved heart function and yielded similar 6-month major cardiovascular events rates in chronic total occlusion patients with and without diabetes, despite collateral circulation differences.
Synapse has enriched 10 related papers. Consider them for comparative context: